BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 7147092)

  • 1. 2'5'-adenylate inhibition of erythropoietin-dependent colony formation.
    Orlic D; Quaini F; Konski AA; Wu JM
    Stem Cells (1981); 1982; 1(4-5):261-8. PubMed ID: 7147092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of CFU-E in rat bone marrow perfused with 2'-5'-oligoadenylate core.
    Orlic D; Kobylack M; Dornfest BS
    Exp Hematol; 1984 Jan; 12(1):39-43. PubMed ID: 6698127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of cadmium on in vitro and in vivo erythropoiesis: erythroid progenitor cells (CFU-E), iron, and erythropoietin in cadmium-induced iron deficiency anemia.
    Sakata S; Iwami K; Enoki Y; Kohzuki H; Shimizu S; Matsuda M; Moriyama T
    Exp Hematol; 1988 Aug; 16(7):581-7. PubMed ID: 3391251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade of the in vitro effects of testosterone and erythropoietin on Cfu-E and Bfu-E proliferation by pretreatment of the donor rats with cyproterone and flutamide.
    Malgor LA; Valsecia M; Vergés E; De Markowsky EE
    Acta Physiol Pharmacol Ther Latinoam; 1998; 48(2):99-105. PubMed ID: 9695882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colony formation in agar by adult bone marrow multipotential hemopoietic cells.
    Johnson GR
    J Cell Physiol; 1980 Jun; 103(3):371-83. PubMed ID: 7400223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies of W mutant mice provide evidence for alternate mechanisms capable of activating hematopoietic stem cells.
    Miller CL; Rebel VI; Lemieux ME; Helgason CD; Lansdorp PM; Eaves CJ
    Exp Hematol; 1996 Feb; 24(2):185-94. PubMed ID: 8641340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The in vitro effect of recombinant erythropoietin on cisdiamminodichloroplatinum-induced inhibition of murine erythroid stem cells.
    Gebbia V; Valenza R; Rausa L
    Anticancer Res; 1990; 10(6):1779-82. PubMed ID: 2285259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors affecting erythroid colony growth (CFU-E) from human marrow.
    Freedman MH; Saunders EF
    Exp Hematol; 1977; 5(4):250-3. PubMed ID: 891664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 2'-5' adenylate (2-5A) system in erythropoiesis.
    Orlic D; Kirk E; Quaini F; Babbott S
    Blood Cells; 1984; 10(2-3):193-210. PubMed ID: 6543650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apoptosis of human erythroid colony-forming cells is decreased by stem cell factor and insulin-like growth factor I as well as erythropoietin.
    Muta K; Krantz SB
    J Cell Physiol; 1993 Aug; 156(2):264-71. PubMed ID: 7688370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropeptide modulation of murine erythropoiesis.
    Skelly RR; Fata J; Sharkis SJ; Sensenbrenner L; Ansari AA
    Ann Clin Lab Sci; 1987; 17(5):324-30. PubMed ID: 2823680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effect of erythropoietin and GM-CSF on megakaryocytopoiesis from primitive bone marrow cells in serum-free conditions.
    Cardier JE; Erickson-Miller CL; Murphy MJ
    Stem Cells; 1997; 15(4):286-90. PubMed ID: 9253112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of anemia and hypertransfusion on neonatal marrow and splenic erythrocytic colony-forming units in vitro.
    Carmichael RD; Orlic D; Lutton JD; Gordon AS
    Stem Cells (1981); 1982; 1(3):165-79. PubMed ID: 7178998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potentiation of erythropoiesis in vitro by dexamethasone.
    Golde DW; Bersch N; Cline MJ
    J Clin Invest; 1976 Jan; 57(1):57-62. PubMed ID: 173742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythropoiesis in vitro. IV. Effects of ouabain on erythroid stem cells (CFU-e and BFU-e).
    Gallicchio VS; Murphy MJ
    Stem Cells (1981); 1981; 1(1):30-7. PubMed ID: 7348866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of recombinant human stem cell factor on mafosfamide-treated bone marrow clonogenic cells.
    Carlo-Stella C; Mangoni L; Almici C; Caramatti C; Rizzoli V
    Stem Cells; 1993 Jul; 11 Suppl 2():170-4. PubMed ID: 7691323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukine-17-induced inhibitory effect on late stage murine erythroid bone marrow progenitors.
    Bugarski D; Krstić A; Vlaski M; Petakov M; Jovcić G; Stojanović N; Milenković P
    Eur Cytokine Netw; 2004; 15(3):247-54. PubMed ID: 15542450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostaglandins activation of erythropoietin production and erythroid progenitor cells.
    Fisher JW; Radtke HW; Jubiz W; Nelson PK; Burdowski A
    Exp Hematol; 1980; 8 Suppl 8():65-89. PubMed ID: 6761139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal erythroid cell production during erythropoietin treatment of mice occurs by exploiting the splenic microenvironment.
    Nijhof W; Goris H; Dontje B; Dresz J; Loeffler M
    Exp Hematol; 1993 Apr; 21(4):496-501. PubMed ID: 8462658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe hypoxia enhances the formation of erythroid bursts from human cord blood cells and the maintenance of BFU-E in vitro.
    Cipolleschi MG; D'Ippolito G; Bernabei PA; Caporale R; Nannini R; Mariani M; Fabbiani M; Rossi-Ferrini P; Olivotto M; Dello Sbarba P
    Exp Hematol; 1997 Oct; 25(11):1187-94. PubMed ID: 9328456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.